Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 3
2007 3
2008 5
2009 4
2010 1
2011 2
2012 6
2013 10
2014 10
2015 10
2016 10
2017 10
2018 15
2019 14
2020 19
2021 12
2022 26
2023 28
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.
Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, D'Hoore A, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Kotze PG, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, Picoraro JA, Vermeire S, Sandborn WJ, Silverberg MS, Pardi DS. Shen B, et al. Among authors: cross rk. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):69-95. doi: 10.1016/S2468-1253(21)00214-4. Epub 2021 Nov 10. Lancet Gastroenterol Hepatol. 2022. PMID: 34774224 Review.
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.
Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y, Cross RK; American Gastroenterological Association Institute Clinical Guidelines Committee. Ko CW, et al. Among authors: cross rk. Gastroenterology. 2019 Feb;156(3):748-764. doi: 10.1053/j.gastro.2018.12.009. Epub 2018 Dec 18. Gastroenterology. 2019. PMID: 30576644 Free PMC article. Review. No abstract available.
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
Cheifetz AS, Abreu MT, Afif W, Cross RK, Dubinsky MC, Loftus EV Jr, Osterman MT, Saroufim A, Siegel CA, Yarur AJ, Melmed GY, Papamichael K. Cheifetz AS, et al. Among authors: cross rk. Am J Gastroenterol. 2021 Oct 1;116(10):2014-2025. doi: 10.14309/ajg.0000000000001396. Am J Gastroenterol. 2021. PMID: 34388143 Free PMC article. Review.
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J, Farraye FA, Kiran RP, Fleshner P, Rosh J, Shah SA, Chang S, Scherl E, Pardi DS, Schwartz DA, Kotze PG, Bruining DH, Kane SV, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, McCormick JT, Picoraro JA, Silverberg MS, Bernstein CN, Sandborn WJ, Vermeire S. Shen B, et al. Among authors: cross rk. Lancet Gastroenterol Hepatol. 2021 Oct;6(10):826-849. doi: 10.1016/S2468-1253(21)00101-1. Epub 2021 Aug 18. Lancet Gastroenterol Hepatol. 2021. PMID: 34416186 Review.
Nothing Compares to U-padacitinib.
Patil SA, Cross RK. Patil SA, et al. Among authors: cross rk. Am J Gastroenterol. 2023 Sep 1;118(9):1556-1557. doi: 10.14309/ajg.0000000000002378. Epub 2023 May 25. Am J Gastroenterol. 2023. PMID: 37439772 No abstract available.
Just Say No…to the Nocebo Effect.
Rossmann L, Cross RK. Rossmann L, et al. Among authors: cross rk. Inflamm Bowel Dis. 2020 Apr 11;26(5):669. doi: 10.1093/ibd/izaa021. Inflamm Bowel Dis. 2020. PMID: 32031637 No abstract available.
Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium.
Kiran RP, Kochhar GS, Kariv R, Rex DK, Sugita A, Rubin DT, Navaneethan U, Hull TL, Ko HM, Liu X, Kachnic LA, Strong S, Iacucci M, Bemelman W, Fleshner P, Safyan RA, Kotze PG, D'Hoore A, Faiz O, Lo S, Ashburn JH, Spinelli A, Bernstein CN, Kane SV, Cross RK, Schairer J, McCormick JT, Farraye FA, Chang S, Scherl EJ, Schwartz DA, Bruining DH, Philpott J, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sandborn WJ, Silverberg MS, Pardi DS, Church JM, Shen B. Kiran RP, et al. Among authors: cross rk. Lancet Gastroenterol Hepatol. 2022 Sep;7(9):871-893. doi: 10.1016/S2468-1253(22)00039-5. Epub 2022 Jul 5. Lancet Gastroenterol Hepatol. 2022. PMID: 35798022 Review.
How Do We Sequence Biologic Therapies in 2019?
George LA, Cross RK. George LA, et al. Among authors: cross rk. Inflamm Bowel Dis. 2020 Mar 4;26(4):617-618. doi: 10.1093/ibd/izz194. Inflamm Bowel Dis. 2020. PMID: 31504548 No abstract available.
Telemedicine in gastroenterology in the wake of COVID-19.
George LA, Cross RK. George LA, et al. Among authors: cross rk. Expert Rev Gastroenterol Hepatol. 2020 Nov;14(11):1013-1015. doi: 10.1080/17474124.2020.1806056. Epub 2020 Aug 18. Expert Rev Gastroenterol Hepatol. 2020. PMID: 32755288 No abstract available.
Complementary and Alternative Medicine.
Quezada SM, Briscoe J, Cross RK. Quezada SM, et al. Among authors: cross rk. Inflamm Bowel Dis. 2016 Jun;22(6):1523-30. doi: 10.1097/MIB.0000000000000761. Inflamm Bowel Dis. 2016. PMID: 27057686 Review.
191 results